Top Health Equity Funds – Mutual Fund Commentary
Source: http://www.zacks.com/stock/news/19768/Top+Health+Equity+Funds+-+Mutual+Fund+CommentaryPosted on Monday, May 4th, 2009 | In Market Commentary, Stocks to Watch
Today we are featuring top-performing “Health” equity mutual funds, which primarily invest in equity securities of healthcare and related companies.
Investors can find such funds by checking out the entire list of the Zacks #1 Rank Health Equity Funds list.
3 Healthy Picks
Morgan Stanley Health Sciences A (HCRAX) seeks capital appreciation. The fund normally invests at least 80% of assets in common stocks (including depositary receipts) of health science companies throughout the world.
Michael Nolan has been the lead manager at the fund since June 2008. The fund has an expense ratio of 1.50%. It distributes dividends annually.
The fund’s top holdings include Johnson & Johnson (JNJ), Pfizer Inc. (PFE) and Merck & Co. Inc. (MRK).
Fidelity Advisor Health Care A (FACDX) was incepted in September 1996 and seeks capital appreciation. It is non-diversified.
The fund normally invests in common stocks and may invest in securities of foreign and domestic issuers. As of January 2009, its portfolio turnover was 134%. Dividend and capital gains, if any, are distributed annually in December.
Wyeth (WYE), Pfizer Inc. (PFE) and Genentech Inc. (DNA) are among its top holdings.
Kinetics Medical Adv A (KRXAX) seeks long-term growth of capital. The fund primarily invests in common stocks, convertible securities, warrants and other securities such as ADRs and IDRs of U.S. and foreign companies engaged in healthcare industry.
This non-diversified fund has topped its benchmark index in terms of total annual returns in the last 1-, 3- and 5-year periods. Unit holders have to make a minimum initial investment of $2,500 to enter the fund.
Its key holdings include Biogen Idec Inc. (BIIB), Johnson & Johnson (JNJ) and Genzyme Corp. (GENZ)
Discover Many More Funds
Learn more about the new Zacks Mutual Fund Rank and discover some of the best market-beating mutual funds by browsing our new mutual funds section. This part of Zacks.com offers a variety of tools, including mutual fund research, a new mutual fund screener, helpful answers to frequently asked questions and quick access to prospectuses and other information.
By applying the Zacks Rank to mutual funds, investors can find funds that not only outpaced the market in the past but are also expected to outperform going forward.
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Adrs, Biogen Idec Inc., Genentech Inc., Genzyme Corp, health, healthcare, Healthcare Industry, IDRs of U.S.;, Johnson, Market Commentary, Merck, Michael Nolan;, Morgan Stanley, Pfizer Inc, Rank Health Equity Funds;, Stocks to Watch, Top Health Equity Funds;, United States, USD, Wyeth, Zacks Market Commentaries
![]() About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |



